• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性缺血性卒中患者既往诊断与同时诊断心房颤动的临床特征及结局比较:诊断时机的影响

Comparative clinical profiles and outcomes of prior vs. concurrently diagnosed atrial fibrillation in acute ischaemic stroke: the implication of diagnosis timing.

作者信息

Ahn Hyo-Jeong, Go Young-Hae, Lee So-Ryoung, Choi JungMin, Lee Kyung-Yeon, Kwon Soonil, Choi Eue-Keun, Oh Seil, Lip Gregory Y H

机构信息

Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

出版信息

Europace. 2025 Jun 3;27(6). doi: 10.1093/europace/euaf107.

DOI:10.1093/europace/euaf107
PMID:40456536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12166361/
Abstract

AIMS

Based on the diagnostic sequence in relation to stroke, a recent classification of atrial fibrillation (AF) categorizes AF into known AF (KAF) and AF detected after stroke or transient ischaemic attack (AFDAS). However, relatively little is known about AF 'concurrently diagnosed with stroke'-perhaps the 'grey zone' of AF between KAF and AFDAS, which has been less characterized in terms of its resemblance to clinical characteristics and outcomes compared with AFDAS or KAF.

METHODS AND RESULTS

Patients with AF who were admitted for acute ischaemic stroke (IS) in 2010-20 were retrospectively reviewed. Clinical characteristics and net clinical outcome (NCO)-the composite of recurrent stroke, major bleeding, hospitalization or emergency department visits for cardiovascular events, and death-were compared between AF diagnosed before stroke (prior AF) and incident AF diagnosed concurrently with IS (AFDCS). A total of 720 patients with AF and acute IS (mean age, 72.5 ± 10.1 years; 60.3% male) were included: prior AF, 62.6% (n = 451), and AFDCS, 37.4% (n = 269). Prior AF presented with more prevalent diabetes, heart failure, vascular disease, and valvular heart disease than AFDCS (all P < 0.05). The AFDCS had a significantly higher left ventricular ejection fraction and smaller left atrial diameter than prior AF. During a median follow-up of 2.0 (interquartile range 0.6-4.6) years, AFDCS was associated with a lower risk of NCO than prior AF without significant differences in the risk of recurrent stroke: adjusted hazard ratio (95% confidence interval), 0.776 (0.611-0.986), P = 0.038 for NCO and 0.784 (0.450-1.365), P = 0.389 for recurrent stroke.

CONCLUSION

Prior AF and AFDCS have distinctive clinical profiles supporting AF is a disease of continuum according to its diagnostic vicinity to the IS. In terms of recurrent IS, AFDCS has a comparable risk with prior AF, indicating the importance of early detection and integrated management of AF for patients with IS.

摘要

目的

基于与卒中相关的诊断顺序,心房颤动(AF)的一种最新分类将AF分为已知AF(KAF)以及在卒中或短暂性脑缺血发作后检测到的AF(AFDAS)。然而,对于“与卒中同时诊断的AF”了解相对较少,这可能是KAF和AFDAS之间AF的“灰色地带”,与AFDAS或KAF相比,其在临床特征和预后方面的相似性方面的特征较少。

方法和结果

对2010 - 2020年因急性缺血性卒中(IS)入院的AF患者进行回顾性研究。比较卒中前诊断的AF(既往AF)和与IS同时诊断的新发AF(AFDCS)的临床特征和净临床结局(NCO),NCO是复发性卒中、大出血、因心血管事件住院或急诊就诊以及死亡的综合指标。共纳入720例AF合并急性IS患者(平均年龄72.5±10.1岁;男性占60.3%):既往AF占62.6%(n = 451),AFDCS占37.4%(n = 269)。既往AF患者的糖尿病、心力衰竭、血管疾病和心脏瓣膜病比AFDCS更常见(均P < 0.05)。AFDCS的左心室射血分数显著高于既往AF,左心房直径小于既往AF。在中位随访2.0(四分位间距0.6 - 4.6)年期间,AFDCS的NCO风险低于既往AF,复发性卒中风险无显著差异:调整后的风险比(95%置信区间),NCO为0.776(0.611 - 0.986),P = 0.038;复发性卒中为0.784(0.450 - 1.365),P = 0.389。

结论

既往AF和AFDCS具有独特的临床特征,支持AF根据其与IS的诊断接近程度是一种连续疾病。就复发性IS而言,AFDCS与既往AF的风险相当,表明对IS患者早期检测和综合管理AF的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41df/12166361/3d20fcf72d0d/euaf107f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41df/12166361/ed8c3d2d3372/euaf107_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41df/12166361/47d018c19c3e/euaf107f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41df/12166361/9b9050576d45/euaf107f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41df/12166361/3d20fcf72d0d/euaf107f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41df/12166361/ed8c3d2d3372/euaf107_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41df/12166361/47d018c19c3e/euaf107f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41df/12166361/9b9050576d45/euaf107f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41df/12166361/3d20fcf72d0d/euaf107f3.jpg

相似文献

1
Comparative clinical profiles and outcomes of prior vs. concurrently diagnosed atrial fibrillation in acute ischaemic stroke: the implication of diagnosis timing.急性缺血性卒中患者既往诊断与同时诊断心房颤动的临床特征及结局比较:诊断时机的影响
Europace. 2025 Jun 3;27(6). doi: 10.1093/europace/euaf107.
2
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
3
Dronedarone for the treatment of atrial fibrillation and atrial flutter.多非利特治疗心房颤动和心房扑动。
Health Technol Assess. 2010 Oct;14(Suppl. 2):55-62. doi: 10.3310/hta14suppl2/08.
4
Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants.接受口服抗凝剂治疗的心房颤动患者的复发性缺血性卒中
JAMA Neurol. 2024 Aug 1;81(8):805-813. doi: 10.1001/jamaneurol.2024.1892.
5
Association of Atrial Fibrillation Burden With Cardiovascular Outcomes in New-Onset Atrial Fibrillation Complicating Myocardial Infarction.新发房颤合并心肌梗死时房颤负荷与心血管结局的关联
J Am Heart Assoc. 2025 May 20;14(10):e039547. doi: 10.1161/JAHA.124.039547. Epub 2025 Apr 16.
6
Systematic screening for the detection of atrial fibrillation.用于检测心房颤动的系统筛查。
Cochrane Database Syst Rev. 2016 Jun 3;2016(6):CD009586. doi: 10.1002/14651858.CD009586.pub3.
7
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.直接口服抗凝剂与不进行抗凝治疗预防伴有心房颤动的脑出血幸存者中风的疗效比较(PRESTIGE-AF):一项多中心、开放标签、随机、3期试验
Lancet. 2025 Mar 15;405(10482):927-936. doi: 10.1016/S0140-6736(25)00333-2. Epub 2025 Feb 26.
8
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): statistical analysis plan for a randomised controlled trial.急性缺血性卒中合并心房颤动后抗凝治疗的最佳时机(OPTIMAS):一项随机对照试验的统计分析计划
Trials. 2025 Feb 19;26(1):58. doi: 10.1186/s13063-025-08761-6.
9
Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.用于预防非瓣膜性心房颤动且无既往卒中或短暂性脑缺血发作史患者卒中的口服抗凝药。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001927. doi: 10.1002/14651858.CD001927.pub2.
10
Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.“口袋里的药丸”策略与偶发性院内治疗或持续性抗心律失常药物治疗相比,用于阵发性心房颤动的系统评价和成本效益评估。
Health Technol Assess. 2010 Jun;14(31):iii-iv, 1-75. doi: 10.3310/hta14310.

本文引用的文献

1
Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association.临床实践、研究及技术开发中的房颤负荷:欧洲心脏病学会卒中委员会与欧洲心律协会的临床共识声明
Europace. 2025 Mar 5;27(3). doi: 10.1093/europace/euaf019.
2
Time-varying differences in stroke recurrence risk between types of atrial fibrillation based on screening methods and timing of detection.基于筛查方法和检测时间的房颤类型之间中风复发风险的时变差异。
Eur Stroke J. 2025 Jun;10(2):461-468. doi: 10.1177/23969873241300888. Epub 2024 Nov 26.
3
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).
心房心肌病再探——概念的演变:欧洲心脏病学会心律协会 (EHRA)、心律学会 (HRS)、亚太心律学会 (APHRS) 和拉丁美洲心律学会 (LAHRS) 的临床共识声明。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae204.
4
Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study.房颤患者卒中后抗栓治疗与净临床结局风险的关联:一项观察性队列研究。
Europace. 2024 Feb 1;26(2). doi: 10.1093/europace/euae033.
5
Atrial fibrillation first detected after stroke: is timing and detection intensity relevant for stroke risk?卒中后首次检测到心房颤动:时间和检测强度与卒中风险相关吗?
Eur Heart J. 2024 Feb 1;45(5):396-398. doi: 10.1093/eurheartj/ehad744.
6
Towards a new classification of atrial fibrillation detected after a stroke or a transient ischaemic attack.卒中和短暂性脑缺血发作后检出的心房颤动的新分类。
Lancet Neurol. 2024 Jan;23(1):110-122. doi: 10.1016/S1474-4422(23)00326-5. Epub 2023 Oct 12.
7
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal.心房颤动与卒中预防:《欧洲心脏杂志》 25 年研究成果
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad226.
8
Differences in Stroke Recurrence Risk Between Atrial Fibrillation Detected on ECG and 14-Day Cardiac Monitoring.心电图和 14 天心脏监测检出的心房颤动患者卒中复发风险的差异。
Stroke. 2023 Aug;54(8):2022-2030. doi: 10.1161/STROKEAHA.123.043672. Epub 2023 Jun 28.
9
Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper.房颤的筛查:更努力、更持久且方式日益精细地进行筛查。一份欧洲心律协会立场文件。
Europace. 2023 Feb 8;25(1):185-198. doi: 10.1093/europace/euac144.
10
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.优化卒中和相关心脏病管理的综合护理:欧洲心脏病学会卒中委员会立场文件。
Eur Heart J. 2022 Jul 7;43(26):2442-2460. doi: 10.1093/eurheartj/ehac245.